TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma
Author:
Funder
Institut National de la Santé et de la Recherche Médicale
Institut National Du Cancer
Fondation pour la Recherche Médicale
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference42 articles.
1. End points for new agents in induction chemotherapy for locally advanced head and neck cancers;Monnerat;Ann Oncol,2002
2. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer;Hitt;J Clin Oncol,2005
3. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer;Vermorken;N Engl J Med,2007
4. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group;Blanchard;J Clin Oncol,2013
5. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J Exp Med,2000
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Durvalumab and taxane family combination therapy enhances the antitumoral effects for NSCLC: An in vitro study;Cell Biochemistry and Function;2024-01
2. PD‐L1 expression in fine‐needle aspiration cell blocks of head and neck squamous‐cell carcinoma and its cytohistological concordance;Diagnostic Cytopathology;2023-12-14
3. PD-L1 expression in recurrent or metastatic head and neck squamous cell carcinoma in China (EXCEED study): a multicentre retrospective study;Journal of Clinical Pathology;2023-11-15
4. Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors;OncoImmunology;2023-11-09
5. The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma;Cancer Immunology, Immunotherapy;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3